Wait, we have a special
offer for you!
Click the button below to get your discount.
Get my coupon now No thanks, I'd like to pay full price
Click the button below to get your discount.
Get my coupon now No thanks, I'd like to pay full price
Only Available By Prescription
Top brand choice
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Redesca HP is a low molecular weight heparin (LMWH) indicated for the prevention and treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE). This anticoagulant is also used in the management of unstable angina and myocardial infarction. Redesca HP is derived from porcine intestinal mucosa and is administered through subcutaneous injection.
Before you buy Redesca, it is crucial that you talk to your healthcare provider about potential side effects and effectiveness.
| Fact Table | |
|---|---|
| Formula | C26H40N2O36S5 (Enoxaparin Sodium) |
| License | Health Canada/FDA approved |
| Bioavailability | ~100% via subcutaneous injection |
| Legal status | Prescription Drug |
| Chemical Name | Enoxaparin Sodium |
| Elimination half-life | Approximately 4.5 hours (after subcutaneous administration) |
| Dosage (Strength) | Varies (e.g., 20 mg, 30 mg, 40 mg, 60 mg, 80 mg, 100 mg, 120 mg, 150 mg) |
| Pregnancy | Considered safe with caution during pregnancy (category B) |
| Brands | Redesca HP, Lovenox |
| Protein binding | Low protein binding |
| PubChem CID | 13109 (for Enoxaparin Sodium) |
| MedlinePlus | Not specifically listed for Redesca HP |
| ChEBI | 635 (Enoxaparin Sodium) |
| ATC code | B01AB05 |
| DrugBank | DB01225 (Enoxaparin Sodium) |
| KEGG | D00754 (Enoxaparin Sodium) |
| Routes of administration | Subcutaneous, intravenous |
Dosage:
For DVT and PE Prevention: Typically, the dosage is 20 mg once daily for patients with low to moderate risk of thromboembolic complications, and 40 mg once daily for those with a higher risk. This medication is usually administered for 7 to 10 days, or as directed by a healthcare provider.
For DVT and PE Treatment: The recommended dose is 1 mg/kg body weight, administered subcutaneously every 12 hours. For patients requiring less frequent dosing, 1.5 mg/kg body weight once daily may be prescribed.
For Unstable Angina or Myocardial Infarction: Typically, 1 mg/kg every 12 hours in combination with oral antiplatelet therapy.
Administration:
Ensure proper technique is used for subcutaneous injections. Inject in fatty areas such as the abdomen or thigh.
Do not mix with other injections or solutions.
Rotate injection sites to prevent skin irritation.
Active Ingredient: Enoxaparin sodium.
Redesca HP should not be used by patients who are allergic to enoxaparin, heparin, or pork products.
Exercise caution when administering to individuals with a past occurrence of heparin-induced thrombocytopenia (HIT).
Not recommended for patients with active major bleeding or conditions that predispose them to bleeding.
Patients with reduced kidney function may require dosage adjustments or additional monitoring to prevent bleeding complications.
Consult a healthcare provider regarding enoxaparin injection use during pregnancy, as it may cross the placenta.
Anticoagulants and antiplatelets: Increased risk of bleeding if used with other drugs that affect blood clotting, such as warfarin, aspirin, and clopidogrel.
Nonsteroidal anti-inflammatory drugs (NSAIDs): Can increase bleeding risk; monitor closely if concurrent use is necessary.
Herbal supplements: Avoid concomitant use of supplements that have anticoagulant effects, such as Ginkgo biloba, garlic, and high doses of fish oil.
Common side effects include:
If you are curious about enoxaparin uses, consult with your healthcare provider to understand its potential benefits and risks for your specific medical condition.
